SCHEMBL218458

SCHEMBL218458

C=COCC1CCC(COC(=O)c2cccc(C(=O)OCC3CCC(COC=C)CC3)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JMJD6 Q6NYC1 2/20 0.45
CARM1 Q86X55 1/20 0.41
PRMT6 Q96LA8 1/20 0.41
CHRNB2 P17787 3/20 0.41
CHRNA4 P43681 3/20 0.41
ROCK2 O75116 5/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
HTR4 Q13639 2/20 0.37
CHRNA5 P30532 1/20 0.37
CHRNA7 P36544 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
ADRA2C P18825 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR1D P28221 1/20 0.36
ADRA1B P35368 1/20 0.36
HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25277718 0.95 NR1H4 (0.43) JMJD6CARM1PRMT6CHRNB2CHRNA4
SCHEMBL217691 0.90 CARM1 (0.51) JMJD6CARM1PRMT6CHRNB2CHRNA4
SCHEMBL218978 0.88 DRD2 (0.45) JMJD6CARM1PRMT6CHRNB2CHRNA4
SCHEMBL2456728 0.83 DRD2 (0.44) JMJD6CARM1PRMT6CHRNB2CHRNA4
SCHEMBL7560468 0.82 JMJD6 (0.49) JMJD6CARM1PRMT6CHRNB2CHRNA4
SCHEMBL12342024 0.81 LMNA (0.49) L3MBTL1
SCHEMBL24438562 0.81 JMJD6 (0.51) JMJD6CARM1PRMT6CHRNB2CHRNA4
SCHEMBL14397614 0.79 CARM1 (0.52) JMJD6CARM1PRMT6CHRNB2CHRNA4
SCHEMBL15187535 0.79 RAB9A (0.52) JMJD6CARM1PRMT6CHRNB2CHRNA4
SCHEMBL13498609 0.78 NPC1 (0.53) JMJD6CARM1PRMT6CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12098298-B2 Ultra-fast UV-cured material for repairing surface imperfections ILLINOIS TOOL WORKS INC. (US) 2024-09-24 US claimed
EP-2288665-A1 SURFACE-PROMOTED CURE OF ONE-PART CATIONICALLY CURABLE COMPOSITIONS Loctite (R & D) Limited (IE) 2011-03-02 EP claimed
WO-2009141444-A1 SURFACE-PROMOTED CURE OF ONE-PART CATIONICALLY CURABLE COMPOSITIONS LOCTITE (R&D) LIMITED (IE) 2009-11-26 WO claimed
US-20090288769-A1 Surface-Promoted Cure of Cationically Curable Compositions Comprising Vinyl Ethers LOCTITE (R&D)LIMITED (IE) 2009-11-26 US claimed
EP-4580818-A1 ONE COMPONENT, UV-CURED PRIMER MATERIAL FOR REPAIRING SURFACE IMPERFECTIONS Illinois Tool Works Inc. (US) 2025-07-09 EP disclosed
US-20250171566-A1 LIQUID, HYBRID UV/VIS RADIATION CURABLE RESIN COMPOSITIONS FOR ADDITIVE FABRICATION STRATASYS INC (US) 2025-05-29 US disclosed
US-12252561-B2 Liquid, hybrid UV/VIS radiation curable resin compositions for additive fabrication STRATASYS, INC. (US) 2025-03-18 US disclosed
US-12098298-B2 Ultra-fast UV-cured material for repairing surface imperfections ILLINOIS TOOL WORKS INC. (US) 2024-09-24 US disclosed
US-20240092946-A1 LIQUID, HYBRID UV/VIS RADIATION CURABLE RESIN COMPOSITIONS FOR ADDITIVE FABRICATION STRATASYS INC (US) 2024-03-21 US disclosed
WO-2024049789-A1 ONE COMPONENT, UV-CURED PRIMER MATERIAL FOR REPAIRING SURFACE IMPERFECTIONS ILLINOIS TOOL WORKS INC. (US) 2024-03-07 WO disclosed
US-20240050666-A1 METHODS AND DEVICES FOR MEDICAMENT DELIVERY PALO ALTO RESEARCH CENTER INCORPORATED (US) 2024-02-15 US disclosed
US-11866526-B2 Liquid, hybrid UV/vis radiation curable resin compositions for additive fabrication STRATASYS, INC. (US) 2024-01-09 US disclosed
WO-2009141444-A1 SURFACE-PROMOTED CURE OF ONE-PART CATIONICALLY CURABLE COMPOSITIONS LOCTITE (R&D) LIMITED (IE) 2009-11-26 WO disclosed
WO-2009053832-A2 BOTTOM ANTIREFLECTIVE COATING COMPOSITIONS AZ ELECTRONIC MATERIALS USA CORP. (DE) 2009-04-30 WO disclosed
US-20090104559-A1 Bottom Antireflective Coating Compositions MERCK PATENT GMBH (DE) 2009-04-23 US disclosed
US-20080090184-A1 Positive -Working Photoimageable Bottom Antireflective Coating MERCK PATENT GMBH (DE) 2008-04-17 US disclosed
US-20080038666-A1 Positive-Working Photoimageable Bottom Antireflective Coating MERCK PATENT GMBH (DE) 2008-02-14 US disclosed
EP-1738225-A2 POSITIVE-WORKING PHOTOIMAGEABLE BOTTOM ANTIREFLECTIVE COATING AZ Electronic Materials USA Corp. (US) 2007-01-03 EP disclosed
WO-2005093513-A2 POSITIVE-WORKING PHOTOIMAGEABLE BOTTOM ANTIREFLECTIVE COATING AZ ELECTRONIC MATERIALS USA CORP. (DE) 2005-10-06 WO disclosed
US-20050214674-A1 Positive-working photoimageable bottom antireflective coating AZ ELECTRONIC MATERIALS USA CORP. 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090104559-A1 Bottom Antireflective Coating Compositions SDC2, S100A9, MYH9 JMJD6 1574/4885CARM1 2306/4885PRMT6 2779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.